Connect your AI

Fulgent Genetics, Inc. FLGT Price / sales

Price / sales at other companies

Bristol-Myers SquibbBMY

2.6×-0.1×

Labcorp HoldingsLH

1.6×+0.1×

Quest DiagnosticsDGX

1.9×+0.1×

NeoGenomicsNEO

1.3×-0.5×

Natera, Inc.NTRA

11.3×+0.9×

Tempus AI, Inc.TEM

5.9×-4.4×

Other financials

Income statement

Revenue$71.1M-3.2%

Gross profit$21.5M-24.2%

Operating income-$34.6M-74.9%

Net income-$24.8M-115%

EPS (diluted)-$0.80-116%

Balance sheet

Cash & equivalents$23.4M-65.2%

Total debt$8.2M+40.5%

Total equity$1.0B-6.9%

Total assets$1.2B-4.1%

Cash flow

Operating cash flow$7.1M+260%

CapEx$5.2M+10.3%

Free cash flow$1.9M+121%

Valuation

Market cap$552.11M-7.1%

Enterprise value$536.92M+0.7%

Profitability

Gross margin38.7%-0.1pp

Operating margin-33.1%+17.4pp

Net margin-23%+43.3pp

FCF margin-36.9%—

Returns & leverage

Return on equity-6.8%+48.2pp

Debt / equity0×0.0×

Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

market cap/total revenue=1.6×

Based on the most recent quarter.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Fulgent Genetics, Inc.'s price / sales?: Fulgent Genetics, Inc. (FLGT) reported price / sales of 1.6× in Q1 2026.
How has Fulgent Genetics, Inc.'s price / sales changed year-over-year?: Fulgent Genetics, Inc.'s price / sales decreased by 13.1% year-over-year, from 1.8× to 1.6×.
What is the long-term trend for Fulgent Genetics, Inc.'s price / sales?: Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s price / sales has grown at a -7.3% compound annual growth rate (CAGR), from 3.7× to 2.5×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.